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Introduction: Heavy cigarette smoking-related chronic obstructive 
pulmonary disease is an independent risk factor for lung squamous 
carcinoma. However, the mechanisms underlying the malignant 
transformation of bronchial epithelial cells are unclear.
Methods: In our study, human tumor-adjacent bronchial epithelial 
cells were obtained from 10 cases with smoking-related chronic 
obstructive pulmonary disease and lung squamous carcinoma and 
cultured in an established microfluidic chip for continual exposure to 
cigarette smoke extracts (CSE) to investigate the potential tumor-like 
transformation and mechanisms. The integrated microfluidic chip 
included upstream concentration gradient generator and downstream 
cell culture chambers supplied by flowing medium containing differ-
ent concentrations of CSE.
Results: Our results showed that continual exposure to low doses 
of CSE promoted cell proliferation whereas to high doses of CSE 
triggered cell apoptosis. Continual exposure to CSE promoted reac-
tive oxygen species production in human epithelial cells in a dose-
dependent manner. More importantly, continual exposure to low dose 
of CSE promoted the epithelial-to-mesenchymal transition process 
and anchorage-independent growth, and increased chromosome 
instability in bronchial epithelial cells, accompanied by activating 
the GRP78, NF-κB, and PI3K pathways.
Conclusions: The established microfluidic chip is suitable for pri-
mary culture of human tumor-adjacent bronchial epithelial cells to 
investigate the malignant transformation. Continual exposure to low 
doses of CSE promoted tumor-like transformation of human nontu-
mor bronchial epithelial cells by inducing reactive oxygen species 
production and activating the relevant signaling.
Key Words: Smoking, Transformation, Epithelial cells, Reactive 
oxygen species, Microfluidic chip
(J Thorac Oncol. 2014;9: 1091–1100)
Cigarette smoking is the most important risk factor of lung cancer, and smokers have a 15- to 30-fold increased 
risk to develop lung cancer.1 Long-term of heavy smoking 
can cause chronic obstructive pulmonary disease (COPD), 
and cigarette smokers account for more than 90% of COPD 
patients in developed countries.2 Recently, a growing body of 
epidemiological studies has consistently demonstrated a link 
between cigarette smoking-related COPD and lung cancer. It 
has been reported that 50% to 70% of lung cancer patients 
also suffer from COPD3 and that smokers with COPD had up 
to a four- to sixfold increased risk of lung cancer.4,5 Therefore, 
COPD is strongly associated with lung cancer and may be a 
surrogate marker for patients’ background with squamous cell 
lung carcinoma.6
However, the molecular mechanisms by which long-
term smoking induces the malignant transformation of bron-
chial epithelial cells and the development of lung cancer have 
not been clarified. Previous studies have shown that heavy 
smoking-related COPD is characterized by excessive inflam-
mation and extracellular matrix destruction7 and shares many 
risk factors with lung cancer in humans. Cigarette smoke 
extract (CSE) can enhance the neoplastic transformation of 
human bronchial epithelial cells,8 and tobacco smoking can 
promote lung tumorigenesis by activating the inflammatory 
signal pathways.9 Other studies reveal that long-term smok-
ing induces chronic lung inflammation and oxidative stress, 
and promote the process of epithelial-to-mesenchymal tran-
sition (EMT), DNA damage, and cellular proliferation.3,10,11 
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Oxidative stress can induce abnormally higher levels of reac-
tive oxygen species (ROS) production, which is a critical factor 
for tumorigenesis.12,13 Cigarette smokers are exposed to many 
types of oxidants, which can cause mitochondrial dysfunction, 
resulting in ROS production and the NF-κB, STAT3, and PI3K 
activation that promote cell proliferation during the malig-
nant transformation.14,15 However, most of these studies are 
performed in cell lines or animal models, and the results may 
not reflect the real process of human bronchial epithelial cells. 
Currently, conventional in vitro models are based on cultur-
ing cells under static conditions, with a fixed concentration of 
media supplement, nutrition composition, or substances from 
cigarettes, which are far away from the real environments in 
vivo. Furthermore, there is no current ideal animal model to 
study on cigarette smoking-induced COPD and lung cancer,16 
and there are only few studies on the tumor-like transformation 
of bronchial epithelial cells from patients with COPD, because 
of limited resource. Therefore, there is an urgent need to estab-
lish a novel model with which we can investigate the molecu-
lar mechanisms underlying the process of continual cigarette 
smoking-induced tumor-like transformation of human nontu-
mor bronchial epithelial cells from COPD patients.
Microfluidic chip technology has been used for sample 
preparation, biological and chemical reaction, separation, and tests 
with many advantages.17,18 Microfluidic chip-based cell cultures 
can continually supply the cells with fresh medium of oxygen and 
nutrition at a controlled flow rate.19 In addition, microfluidic chip 
can be sued for high-throughput tests and has been widely used 
in the field of drug screening, single cell analysis, and cell sig-
nal pathway research.20 Thus, the microfluidic chip may provide 
a unique and ideal platform to study the continual exposure of 
primarily cultured human bronchial epithelial cells to CSEs.
In this study, we built a microfluidic chip for continual 
exposure of primarily cultured human bronchial epithelial cells 
to CSE to investigate their tumor-like transformation and poten-
tial molecular mechanisms. We employed human nontumor 
bronchial tissues from 10 patients with lung cancer and smok-
ing-related COPD to obtain bronchial epithelial cells because 
these nontumor bronchial tissues surrounding the tumor mass 
are already exposed to cigarette smoking and chronic inflam-
mation.21 We found that continual exposure to CSE promoted 
the tumor-like transformation of primarily cultured human non-
tumor bronchial epithelial cells in the microfluidics by inducing 
endoplasmic reticulum stress and ROS production, and activat-
ing the NF-κB and PI3K/AKT/mTOR signaling.
MATERIALS AND METHODS
The Fabrication of Microfluidic Chip
A microfluidic chip contained four parallel operating mod-
ules for simultaneous culture of four cell samples (Fig. 1A) and 
one module including a concentration gradient generator (CGG), 
six main channels (width 300 μm, height 100 μm), and 18 cell 
chambers (diameter 2.5 mm, height 100 μm, Fig. 1B). The CGG 
included five cascaded-mixing stages that generated linear con-
centrations by adjusting the flow rate of two merging solutions 
in each stage through controlling channel length, which was 
proportional to fluidic resistance. When the cell culture medium 
and CSE were filled into channels by a syringe pump, the CGG 
theoretically produced at least six different concentrations of 
CSE media (with CSE proportions of 0:1:3:5:7:9). A microfluidic 
chip is shown in Figure 1C. The polydimethylsiloxane (PDMS) 
microfluidic chip was fabricated using a Sylgard 184 kit (Dow 
Corning, Midland, TX) by a standard soft lithography method. 
Briefly, PDMS was fabricated by replica molding against mas-
ters, and bonded to a glass slide that had been treated with oxygen 
plasma (150 mTorr, 50 W, 25s). The finished PDMS microfluidic 
chip was first treated with dehydrated alcohol then distilled water, 
and autoclaved at 120°C and 103.4kPa for 30 minutes.
Specimen Collection and Tumor-Adjacent 
Bronchial Epithelial Cell Culture
This study was approved by the Institutional Review 
Board and Human Ethics Committee of the First Affiliated 
Hospital of Dalian Medical University, and written informed 
consent was obtained from individual patients. A total of 10 
patients with lung squamous carcinoma and surgical treat-
ment were recruited in the First Affiliated Hospital of Dalian 
Medical University, China, from January 2013 to May 2013 
(see Table, Supplemental Digital Content 1, http://links.lww.
com/JTO/A607, which demonstrates the demographic and 
clinical data). The criteria for the enrollment of patients were 
as follows: (1) pathological identification of a lung squamous 
carcinoma; (2) a history of COPD with current lung function 
(FVE1/FVC less than 70%, 2011 GOLD); (3) a history of cig-
arette smoking for more than 40 pack-years; and (4) currently 
without any other respiratory disease, such as tuberculosis.
After surgical removal of tumor, the tumor-adjacent bron-
chial tissues were dissected and the connective tissue, mucus, 
and blood clot in the samples were removed. The remaining 
bronchial tissues were cut into small pieces of approximately 
1 mm3 and cultured on six-well plates precoated with placenta 
collagen IV (Sigma Aldrich, St. Louis, MO) in serum-free air-
way epithelial cell medium (Promocell, Heidelberg, Germany) 
at 37°C in a humidified atmosphere of 5% of CO
2
. The cells 
were exposed to fresh medium every other day until the cells 
reached 80% confluence. Subsequently, the structure of cells 
was examined by hematoxylin-eosin (H&E) staining, and the 
expression of cytokeratin 19 (CK19) was determined by immu-
nofluorescent assay using specific antibody (Abcam, ab15463).
CSE Preparation
CSE was prepared, as described previously.22 Briefly, 
the smoke from two lit cigarettes (Research Grade Cigarette, 
University of Kentucky) was collected into 50 ml serum-free 
medium using constant vacuum flow. The CSE solution was 
filtrated through a 0.22-μm pore filter and utilized in experi-
ments within 30 min.
Continual Exposure of Human Tumor-
Adjacent Bronchial Epithelial Cells 
to CSE in a Microfluidics
The tumor-adjacent human bronchial epithelial cells 
were harvested, adjusted to a density of 1 × 106 cells/ml in 
medium, and were injected into the cell inlets #1–#6 of the 
microfluidic chip using a syringe pump at a constant flow rate 
of 8 μL/min for 10 seconds. After the cells were attached, the 
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cells were supplied with complete medium at a constant rate 
of 5 μL/min for 48 hours, by a syringe pump in a perfusion 
mode. When the cells reached 80% confluence, the cells were 
exposed to different concentrations of CSE in medium by 
simultaneously infusing medium and different concentrations 
of CSE stock solutions into the chip through the CSE inlet and 
medium inlet at a constant rate of 7 and 5 μL/min, respectively.
Proliferation and Apoptosis Assay of 
Human Bronchial Epithelial Cells
The impact of CSE on cell proliferation was determined 
using a Cell-Light EdU Apollo 488 in vitro Kit (Ribobio, 
Guangzhou Ribobio Company, China), according to the man-
ufacturers’ instruction. Briefly, cells (1000/chamber) were 
treated with, or without, CSE for 48 hours and labeled with 
EdU for 2 hours. The cells were fixed, stained for Apollo and 
DNA, and examined under a fluorescent microscope (Olympus 
IX71, Japan, magnification factor ×200). The effect of CSE on 
cell apoptosis was determined by staining with Hoechst33342 
and propidium iodide staining (Sigma Aldrich).
The Detection of ROS and Its Related 
Signaling Pathways in the Cultured 
Human Bronchial Epithelial Cells
The levels of cytoplasmic ROS were characterized using 
a ROS Assay kit, according to the manufacturers’ instruction 
(Beyotime Biotechnology, Jiangsu, China). Briefly, cells were 
treated with, or without, CSE for 48 hours and stained with 
DCFH-DA for 20 minutes by injecting fluorescent probe in 
medium (1:1000) into the chambers, followed by examining 
under a fluorescent microscope.
The impact of ROS on the GRP78, NF-κB, and PI3K 
expression was determined by immunofluorescent assays. 
Briefly, cells were pretreated with, or without, a ROS inhibi-
tor N-acetylcysteine (NAC, 20 mM, Sigma ) for 12 hours 
and exposed to CSE for 3 hours. The cells were fixed with 
FIGURE 1.  Fabrication of a microfluidic chip for 
cell culture. A, The designed microfluidic chip 
containing four parallel operating modules. (B) 
Magnified section of an operating module includ-
ing one media inlet, one cigarette smoke extract 
(CSE) inlet, one concentration gradient genera-
tor (CGG), 18 parallel cell chambers, and six cell 
inlets. The fabricated CGG inside the microfluidic 
chip (in the blue box) can produce six different 
concentrations of CSE (theoretical proportion 
0:1:3:5:7:9). The black represents CSE and the red 
represents medium. A concentration gradient of 
CSE was obviously shown from inlet one to six. (C) 
The image of an operating module in the micro-
fluidic chip viewed from above.(D) Representative 
images of the histological examination of the 
surgical specimens of lung cancer tissues, includ-
ing lung cancer area (a) and tumor-adjacent 
bronchus (b, black arrow, scale bar 100 μm). (E) 
The structure of the cells under a light microscope 
after cultured from day 5 to 15 (white arrow: 
the tumor-adjacent bronchus). (F) Cytological 
identification of the primarily cultured epithelial 
cells by H&E and anti-CK19 immunofluorescent 
staining. (G) The schematics of the primarily 
cultured bronchial epithelial cells that exposed to 
CSE on the microfluidic chip. The microfluidic chip 
with a syringe pump supplied medium and CSE 
simultaneously to the cells through the inlet. The 
CGG integrated in the microfluidic chip produced 
a concentration gradient of CSE. The primarily 
cultured cells (a) obtained from the case 1 grew in 
the microfluidic chip without CSE for 2 weeks and 
the cell apoptosis was assayed by Hoechst33342/
propidium iodide staining and the percentages 
of red nuclei in blue nuclei was less than 10% (b, 
scale bar 100 μm).
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4% paraformaldehyde, permeabilized, and blocked by 5% 
goat serum. Subsequently, the cells were stained with 1:200 
diluted anti-GRP78 (Santa Cruz), anti-phospho-IRE1α 
(Abcam, ab48187), anti-phospho-IKKα (Beijing Biosynthesis 
Biotechnology, China), anti-NF-κB p65 (Abcam, ab7970), 
anti-cyclin D1 (Abcam, ab16663), anti-PI3Kp85 (Abcam, 
ab86714), anti-phospho-AKT (Cell Signaling Technology), 
and anti-phospho-mTOR (Santa Cruz) overnight at 4°C, 
respectively. After being washed, the bound antibodies were 
detected using Dylight488 or Dylight594-labeled secondary 
antibodies (1:400, Jackson ImmunoResearch Laboratories) at 
37°C for 1 hour. The cells were examined and imaged under a 
fluorescence microscope.
The expression of GRP78, NF-κB, and PI3K in the lung 
cancer tissues was determined by immunohistochemistry23 
using antibodies against GRP78, NF-κB, and PI3K and the 
SP-9000 Histostain TM-Plus Kits (ZYMED).
Detection of E-cadherin and 
Vimentin Expression
The impact of CSE on the E-cadherin and Vimentin expres-
sion was determined by immunofluorescent assays. Briefly, the 
cultured cells in the chambers were pretreated with, or without, 
20 mMNAC, GRP78 inhibitor 4-phenylbutyrate (4-PBA, 5 mM, 
Sigma), NF-κB inhibitor BAY11-7082 (2 μM, InvivoGen) or 
PI3K inhibitor LY294002 (50 μM, Sigma) for 12 hours and then 
exposed to CSE for 48 hours twice a week for 8 weeks. The cells 
were fixed, permeabilized, and stained with 1:200 diluted anti-E-
cadherin (Epitomics) or anti-Vimentin (Abcam), and were visu-
alized using Dylight488-labeled secondary antibodies, followed 
by examining under a laser scanning confocal microscope.
In addition, the relative levels of E-cadherin and 
Vimentin expression were determined by Western blot. Briefly, 
cells at 105/well were cultured in six-well plates, pretreated, 
and treated for 8 weeks, as described earlier. The cell lysates 
were separated by SDS-PAGE and transferred to nitrocellu-
lose membrane (Pall). After being blocked with 5% fat-free 
milk, the membranes were incubated with antibodies against 
E-cadherin (Epitomics, 1:1000), Vimentin (abcam, 1:1000), 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 
Sigma,1:5000), and the bound antibodies were detected using 
a Super Signal West Pico Kit (Thermo), followed by quantita-
tively densitometric analyses using the Eagle Eye II software.
Anchorage-Independent Growth Assay
The impact of CSE on anchorage-independent growth 
of human bronchial epithelial cells was examined. Briefly, 
after being exposed to CSE for 8 weeks, the cells at 2000/well 
were cultured in 0.3% low-melt agarose (Sigma) in complete 
medium that were overlaid on 0.6% agarose in six-well plates 
for 2 weeks. Individual cell colonies with more than 50 cells 
were counted under a microscope.
Chromosome Analysis
Cells were pretreated with, or without, inhibitors for 12 
hours, as described above, and exposed to CSE for 48 hours twice 
a week for 8 weeks. The cells were treated with 0.04 μg/ml of 
colchicines for 4 hours and subjected to chromosome analysis.24
Statistic Analyses
All experiments were performed at least for three times. 
Data are expressed as the means ± SD. The difference among 
groups was analyzed by analysis of variance using SPSS13.0 
for Windows software. p value less than 0.05 was considered 
statistically significant.
RESULTS
Culture of Human Bronchial Epithelial 
Cells on a Microfluidic Chip
To test the feasibility of a microfluidic chip for culturing 
cells, 10 surgical lung squamous carcinomas (Fig. 1Da) were 
obtained and their tumor-adjacent human bronchi (Fig. 1Db) 
were cut into small pieces. After culture of small pieces of non-
tumor tissues for varying periods, human bronchial epithelial 
cells migrated from the tissues, proliferated, and exhibited in 
single-layer growth (Fig. 1E). The cells displayed a typical struc-
ture of lung epithelial cells and expressed CK19, an indicative 
of epithelial character (Fig. 1F). After incubation of the cells 
in the microfluidic chambers supplied with continually flowing 
medium for 2 weeks, the cells remained in epithelial structure 
(Fig. 1Ga) and approximately less than 10% of the cells only 
underwent apoptosis (Fig. 1Gb). In addition, we observed that 
the cells from most of the samples survived about 10 weeks in 
the microfluidic chip. These observations clearly demonstrated 
that the established microfluidic chip was successful to culture 
human primary nontumor bronchial epithelial cells.
The Effect of CSE on Cell 
Proliferation and Apoptosis
To investigate the effect of continual CSE exposure 
on the survival, human bronchial epithelial cells were con-
tinually exposed to medium containing different percentages 
(2.37–91.88%) of CSE for 48 hours and the percentages of 
cell proliferation and apoptosis were quantitatively analyzed 
in Figure 2A. Treatment with lower doses (2.37–12.28%) of 
CSE seemed to stimulate human epithelial cell proliferation 
in a dose-dependent manner, but did not trigger cell apopto-
sis. In contrast, treatment with higher doses (19.86–91.88%) 
of CSE induced human bronchial epithelial cell apoptosis in 
a dose-dependent manner. A similar pattern of cell prolifera-
tion and apoptosis was observed by fluorescent staining (Fig. 
2B,C). Interestingly, treatment with lower doses of CSE for 3 
or 8 weeks continually stimulated human bronchial epithelial 
cell proliferation in the microfluidic chip (Fig. 2D). Therefore, 
continual exposure to different doses of CSE had opposite 
effects on the proliferation and survival of primarily cultured 
human bronchial epithelial cells.
Continual Exposure to CSE Induces ROS 
Production and Activates the Relevant 
Signal Pathways in Primarily Cultured 
Human Bronchial Epithelial Cells
Cigarette smoking induces oxidative stress. Next, we 
tested the effect of continual exposure to CSE on the ROS 
production and relevant signaling. The isolated bronchial 
epithelial cells were treated with different concentrations 
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of CSE for 3 hours and stained with DCFH-DA. The mean 
intensity of fluorescent staining in the cells from indi-
vidual patients was quantitatively analyzed in Figure 3A. 
Apparently, treatment with CSE induced ROS production 
in a dose-dependent manner and a representative pattern of 
fluorescent images from the case 5 is shown in Figure 3B. 
Analysis of the ROS-related signaling revealed that increased 
levels of GRP78 expression and IRE1α phosphorylation 
were detected in the cells following treatment with CSE for 
30 minutes. The IKKα phosphorylation, NF-κB nuclear 
translocation, and cyclin D1 expression were detected in 
the cells at 1 hour post CSE exposure. Similarly, increased 
levels of PI3K expression, AKT and mTOR phosphorylation 
were also detected in the cells at 1 hour post CSE exposure 
(Fig. 4A). However, in comparison with that in the cells with-
out exposure to CSE or NAC, there was no obvious change 
FIGURE 2.  Continual exposure to different doses of cigarette smoke extract (CSE) affects the proliferation and apoptosis of 
human bronchial epithelial cells. Human bronchial epithelial cells were exposed to CSE at the indicated concentrations for 
24 hours and the proliferation and apoptosis of cells were determined by EdU and Hoechst33342/propidium iodide staining, 
respectively. Additional cell proliferation assays were performed at 3 and 8 weeks post CSE exposure. Data are representative 
images and expressed as individual means of percentages of cell proliferation and apoptosis from 10 samples from 10 sepa-
rate experiments. A, The percentages of cell proliferation and apoptosis. *p less than 0.05 versus the controls. The horizontal 
lines reflect the median values for each group of cells. (B) Fluorescent assay of cell proliferation (the green nucleus cells). (C) 
Fluorescent assay of cell apoptosis (the red nucleus cells). (D) Fluorescent images of cell proliferation at the indicated periods 
(scale bar 100 μm).
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in the levels of GRP78 and PI3K expression and NF-κB 
phosphorylation in the cells that had been treated with NAC 
before exposure to CSE (Fig. 4B). Hence, these data suggest 
that continual exposure to CSE induced ROS production, 
which sequentially activated the GRP78/IRE1α, NF-κB, and 
PI3K/AKT/mTOR pathways in primarily cultured human 
bronchial epithelial cells in vitro.
To understand the importance of the activation of these 
pathways, we characterized the GRP78, PI3K, and NF-κB 
expression in 10 lung cancer samples by immunohistochemis-
try (see Figure, SDC 2, http://links.lww.com/JTO/A608, which 
demonstrates the expressions of GRP78, PI3K, and NF-κB 
in lung cancer tissues). There were obviously higher levels 
of GRP78, PI3K, and NF-κB expression in the carcinoma 
areas, when compared with that in the paracarcinoma areas. 
There were seven of 10 samples with positive staining for anti-
GRP78, eight with positive staining for anti-NF-κB, and five 
with positive staining for anti-PI3K. These data suggest that 
aberrant activation of the GRP78/IRE1α, NF-κB, and PI3K/
AKT/mTOR pathways induced by continual exposure to CSE 
may reflect the tumor-like transformation of primarily cultured 
human bronchial epithelial cells in our experimental conditions.
Low Dose of CSE Promotes the Process of 
EMT in Human Bronchial Epithelial Cells
Tumor cells can lose their epithelial characters and are 
subjected to the EMT process. Accordingly, we analyzed the 
relative levels of E-cadherin and Vimentin expression after 
continual exposure to CSE in human bronchial epithelial 
cells. We found that continual exposure to CSE for 3 weeks 
obviously reduced the levels of E-cadherin, but increased 
the levels of Vimentin expression in human bronchial epi-
thelial cells, suggesting that continual exposure to CSE pro-
moted the EMT process of human bronchial epithelial cells 
in the microfluidic chip (Fig. 5A). Furthermore, continual 
exposure to CSE for 8 weeks enhanced the EMT process in 
human bronchial epithelial cells (data not shown). However, 
the reduced E-cadherin and increased Vimentin expression 
induced by CSE were not detected in the cells that had been 
pretreated with NCA, BAY11-7082, 4-PBA, or LY294002. 
A similar pattern of E-cadherin and Vimentin expression 
was detected in the different groups of cells by Western blot 
assays (Fig. 5B). The modulation in the levels of E-cadherin 
and Vimentin induced by CSE exposure was abrogated by 
pretreatment with an inhibitor for ROS or relevant signaling. 
These two lines of evidence demonstrated that continual CSE 
exposure promoted the EMT process in human bronchial epi-
thelial cells, which was mediated by ROS-related signaling.
Continual Exposure to CSE Induces 
Tumor-Like Transformation of Human 
Primary Bronchial Epithelial Cells
Tumor-like transformation of nontumor epithelial cells 
usually changes their structure. To determine the potential 
tumor-like transformation induced by continual exposure to 
CSE, we characterized the morphological changes in human 
bronchial epithelial cells longitudinally. After treatment with 
CSE (12.28%) for 3 weeks, there were some cells with con-
densed nuclei and abnormal nuclear-cytoplasmic ratios, 
accompanied by atypical mitoses in the CSE-exposed cells, 
but not in the cells that had been pretreated with the indi-
cated inhibitor (Fig. 6A). The percentages of abnormal cells 
increased with prolonged CSE exposure (data not shown). 
Furthermore, continual exposure to CSE for 4–6 weeks pro-
moted multiple layers of cell growth, an indicative of the 
loss of contact inhibition (Fig. 6B), which was not in the 
cells pretreated with an inhibitor indicated. In addition, con-
tinual exposure to CSE stimulated the colony formation and 
pretreatment with an inhibitor indicated either completely pre-
vented or significantly reduced the numbers of cell colonies 
(Fig. 6C and D). These data indicated that continual exposure 
to CSE promoted the anchor-independent growth of human 
FIGURE 3.  Continual exposure to different 
doses of cigarette smoke extract (CSE) induces 
reactive oxygen species (ROS) production in 
human bronchial epithelial cells in a dose-
dependent manner. Human bronchial epithelial 
cells were exposed to CSE at the indicated doses 
for 3 hours and the contents of intracellular ROS 
were determined by fluorescent probe DCFH-DA. 
Data are representative images and expressed as 
individual means of the intensity of fluorescent 
staining per cell from 10 samples. (A) The levels 
of intracellular ROS after normalized to cell num-
bers. *p less than 0.05 versus the controls. The 
horizontal lines reflect the median values for each 
group of cells. (B) Fluorescent images of intracel-
lular ROS levels (scale bar 15 μm).
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bronchial epithelial cells, an indicative of tumor-like transfor-
mation of human nontumor epithelial cells, which were associ-
ated with low amount of ROS production and related signaling.
Low Dose of CSE Causes the Chromosome 
Instability of Human Bronchial Epithelial Cells
To further demonstrate the tumor-like transformation 
of human bronchial epithelial cells induced by CSE exposure, 
human bronchial epithelial cells were treated with, or without, 
CSE for 8 weeks and their chromosomes were analyzed. The 
cells without exposure to CSE displayed diploid, whereas the 
CSE-exposed cells were hypodiploid or hyperdiploid (Fig. 6E). 
Some CSE-treated cells exhibited abnormal chromosomes, 
such as dicentric chromosomes, and these abnormal chromo-
somes were not observed in the cells that had been pretreated 
with an inhibitor indicated. Quantitative analysis indicated that 
continual exposure to CSE induced a higher frequency of human 
bronchial epithelial cells with chromosome instability, which 
was abrogated by pretreatment with an inhibitor indicated (Fig. 
6F). The morphological changes, anchor-independent growth, 
and higher frequency of cells with chromosome instability, 
together with high levels of the EMT process, suggest that con-
tinual exposure to CSE may induces tumor-like transformation 
of human nontumor bronchial epithelial cells in vitro.
DISCUSSION
In this study, we built a microfluidic chip and established 
a cellular model of continual CSE exposure of human nontumor 
bronchial epithelial cells from 10 surgical samples from patients 
with lung squamous carcinoma and smoking-related COPD to 
investigate the potential mechanisms underlying tumor-like 
transformation. Our studies lead to the after novel discoveries: 
FIGURE 4.  Continual cigarette 
smoke extract (CSE) exposure 
activates the GRP78, NF-κB, and 
PI3K pathways in human bronchial 
epithelial cells. Human bronchial 
epithelial cells were exposed to CSE 
(12.5%) and the GRP78, NF-κB, 
and PI3K signaling was detected by 
immunofuorescent staining at the 
indicated time points. Additional 
cells were pretreated with 20 mM 
NAC and exposed to CSE for 3 hours 
and the GRP78, NF-κB, and PI3K 
signaling was detected by immuno-
fluorescent staining. Data shown are 
representative fluorescent images 
from 10 separate experiments. The 
GRP78 and NF-κB pathways were 
labeled by Dylight488 (green) and 
the PI3K pathway was labeled by 
Dylight594 (red, scale bar 10 μm). A, 
Longitudinal assays of the activation 
of GRP78, NF-κB, and PI3K path-
ways. (B) The activation of GRP78, 
NF-κB, and PI3K was abrogated by 
pretreatment with NAC.
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First, continual exposure to different doses of CSE had dual 
effects on the proliferation and survival of primarily cultured 
human bronchial epithelial cells. Second, continual exposure to 
CSE induced ROS production in a dose-dependent manner and 
moderate levels of ROS were associated with tumor-like trans-
formation of human nontumor bronchial epithelial cells by acti-
vating the GRP78, NF-κB, and PI3K pathways. Third, continual 
CSE exposure promoted the EMT process, anchor-independent 
growth, and higher frequency of cells with chromosome insta-
bility in human bronchial epithelial cells, which was abrogated 
by pretreatment with a ROS scavenger. Fourth, the microfluidic 
chip was an excellent platform for the investigation of malig-
nant transformation of nontumor bronchial epithelial cells and 
had many advantages over conventional in vitro cellular mod-
els. Our results extended previous findings25,26 and support the 
notion that heavy smoking-related oxidative stress, endoplas-
mic reticulum (ER) stress, and associated inflammation are cru-
cial for inducing tumor-like transformation of human nontumor 
bronchial epithelial cells in vitro.
COPD is an inflammatory lung disease associated with 
heavy smoking. During the pathogenic process, heavy smok-
ing induces oxidative stress and ROS production. Previous 
studies have shown that high levels of ROS can trigger epi-
thelial cell apoptosis, whereas low levels of ROS can stimu-
late the proliferation, invasiveness, and metastasis of lung 
cancer cells by activating the NF-κB, AP-1, PI3K, MAPKs, 
and others.27 In this study, we found that continual exposure 
to different doses of CSE induced ROS production in human 
nontumor bronchial epithelial cells in a dose-dependent man-
ner. Although continual exposure to higher doses of CSE to 
induce high levels of ROS triggered human bronchial epithe-
lial cell apoptosis, continual exposure to lower doses of CSE 
to induce moderate levels of ROS promoted the proliferation 
of human bronchial epithelial cells. More importantly, contin-
ual exposure to low dose of CSE activated the GRP78, NF-κB, 
and PI3K pathways in human bronchial epithelial cells, which 
was abrogated by pretreatment with NAC. In addition, we 
detected aberrant activation of these pathways in the corre-
sponding lung cancer tissues of these patients. Previous stud-
ies have shown that aberrant activation of the NF-κB and PI3K 
is crucial for malignant transformation of epithelial cells,28,29 
and ER stress is associated with the development of COPD in 
heavy smokers and drug-resistance in lung cancer patients.30,31 
It is possible that continual CSE exposure to produce moder-
ate levels of ROS may promote tumor-like transformation of 
human nontumor bronchial epithelial cells.32
It is well known that malignant cells can undergo the EMT 
process and anchorage-independent growth and show chromo-
some aberration and unequal structure. Although E-cadherin 
expression is usually attenuated in all three subtypes of EMT, 
Vimentin, a cytoskeletal marker, is often induced when EMT 
occurs. Recently, Vimentin is frequently used to indentify cells 
undergoing type 3 EMT in cancers.33,34 We found that con-
tinual CSE exposure increased the levels of Vimentin expres-
sion, but reduced the levels of E-cadherin expression in human 
bronchial epithelial cells, an indicative of the EMT process. 
Furthermore, continual CSE exposure promoted anchorage-
independent growth of human bronchial epithelial cells and 
increased the frequency of cells with chromosome instability, 
accompanied by some cells with condensed nuclei, abnormal 
nuclear-cytoplasmic ratios, and atypical mitoses. These sev-
eral lines evidence clearly indicated that continual exposure to 
moderate dose of CSE promoted tumor-like transformation of 
human primarily cultured nontumor bronchial epithelial cells 
in vitro. However, these tumor-like changes were abrogated 
by pretreatment with NAC, GRP78 inhibitor 4-PBA, NF-κB 
inhibitor BAY11-7082, and PI3K inhibitor LY294002. These 
data suggested that moderate levels of ROS and associated 
GRP, NF-κB, and PI3K activation induced by continual CSE 
exposure are crucial for tumor-like transformation of human 
FIGURE 5.  Continual cigarette 
smoke extract (CSE) exposure 
modulates the levels of E-cadherin 
and Vimentin expression in human 
bronchial epithelial cells. Human 
bronchial epithelial cells were 
pretreated with, or without, NAC, 
BAY11-7082, 4-PBA, or LY294002 
for 12 hours and then exposed to 
CSE for 48 hours twice per week 
for 8 weeks. The relative levels of 
E-cadherin and Vimentin were deter-
mined by immunofluorescent stain-
ing and Western blot assays. Data are 
representative images and expressed 
as the means ± SD of each group 
cells from five separate experiments. 
(A) Immunofluorescent images of 
E-cadherin and Vimentin expression. 
(B) Western blot analysis of the rela-
tive levels of E-cadherin and Vimentin 
expression. *p less than 0.05 versus 
the controls. #p less than 0.05 versus 
the CSE-exposed cells.
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bronchial epithelial cells. Therefore, these findings may pro-
vide new insights into the molecular mechanisms underlying 
the link of heavy smoking-related COPD with lung squamous 
carcinoma in humans. We are interested in further investigat-
ing whether continual exposure to CSE can also induce tumor-
like transformation of human nontumor bronchial epithelial 
cells from nonsmoking patients with lung squamous carci-
noma, from nontumor patients, and from nonsmoking nontu-
mor patients. To the best of our knowledge, this was the first 
report on that continual CSE exposure to induce tumor-like 
transformation of human nontumor bronchial epithelial cells 
from patients with heavy smoking-related COPD and lung 
squamous carcinoma. Conceivably, therapeutic target oxida-
tive stress, ER stress, and aberrant activation of these pathways 
may be valuable for prevention from the development of squa-
mous carcinoma in heavy smoking-related COPD patients.
The microfluidic chip used in this study was a unique 
and ideal platform for studying the tumor-like transformation 
of bronchial epithelial cells induced by continual CSE exposure 
because the process of CSE exposure is similar to heavy smoking 
FIGURE 6.  Continual cigarette 
smoke extract (CSE) exposure 
induces tumor-like transformation 
of human bronchial epithelial cells. 
Human bronchial epithelial cells were 
pretreated with, or without, NAC, 
BAY11-7082, 4-PBA, or LY294002 
for 12 hours and then exposed to 
CSE for 48 hours twice per week 
for 8 weeks. The cell structure and 
anchor-independent growth of 
human bronchial epithelial cells were 
examined and the percentages of 
cells with chromosome instability 
were determined. Data are repre-
sentative images and expressed 
as the means ± SD of each group 
of cells from five separate experi-
ments. A, Morphological changes 
of the cells. Black arrow: the cells 
with condensed nucleus staining, 
high nuclear-cytoplasmic ratios and 
atypical mitoses (scale bar 10 μm). 
(B) Multilayer growth of cells (black 
arrow, scale bar 10 μm). (C) Colony 
formation of cells (scale bar 10 μm). 
(D) Quantitative analysis of the 
percentages of colonies. (E) Analysis 
of the cell karyotypes. Red arrow: the 
aberrant chromosome (scale bar 5 
μm). (F) The distribution of the cell 
karyotype. *p less than 0.05 versus 
the controls. #p less than 0.05 versus 
the CSE-exposed cells.
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in humans. Its minute structure, high-oxygen permeable PDMS 
materials, and a continuously flowing medium can mimic a real 
microenvironment in vivo and meet the requirements of primar-
ily cultured human bronchial epithelial cells.18 Therefore, com-
pared with that from conventional platform, the research results 
from the microfluidic chip may be more reliable and meaning-
ful. Furthermore, this microfluidic chip we built can be sued for 
high-throughput screening for the potential signal pathways and 
therapeutic targets with time-lapse imaging. With one device, we 
tested four samples for several conditions simultaneously, which 
reduced the experimental errors. More importantly, the micro-
fluidic chip allowed both the morphological tracing and the fluo-
rescence marker detection to fulfill the dynamic observation of 
cultured cells and their signaling during the long-term exposure 
of a carcinogen. Indeed, we monitored three signal pathways, 
including eight factors in the cultured cells in real time only on 
a chip. The dynamics of the intracellular signaling in the cell 
from 10 specimens were recorded in a short period. Thus, this 
designed microfluidic chip is a unique platform for studying the 
proliferation, apoptosis, and tumor-like transformation of pri-
marily cultured bronchial epithelial cells and other types of cells.
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